Faculty Profile

Dr. Dawn C. Buse, Ph.D.

Dawn C. Buse, Ph.D.

Clinical Professor, The Saul R. Korey Department of Neurology

Professional Interests

Dawn C. Buse PhD is a Clinical Professor of Neurology at Albert Einstein College of Medicine in New York City, an Assistant Professor in the Clinical Health Psychology Doctoral Program of Ferkauf Graduate School of Psychology and was the Director of Behavioral Medicine at the Montefiore Headache Center from 2006-2018.  She is a licensed psychologist and is a Board Member and a fellow of the American Headache Society (AHS).

Dr. Buse conducts research on migraine, pain and stress among other conditions and is a co-investigator on the American Migraine Prevalence and Prevention (AMPP) Study, the Chronic Migraine Epidemiology and Outcomes (CAMEO) Study, the International Burden of Migraine (IBMS) Study, the Migraine, Symptoms and Treatment in America (MAST) Study and the Migraine Signature Study.  She has coauthored more than 100 manuscripts in peer reviewed scientific journals, 54 review articles and book chapters and more than 400 scientific abstracts.  Her manuscripts have won the American Headache Society’s “Wolff Award” twice (2008 and 2018), the Italian Society for the Study of Headache’s “Enrico Greppi Award” twice (2009 and 2017), the British Medical Journal’s “Patient’s Choice Award”, and the 2015 “Headache Reader’s Choice” Award.  In 2009 she won the National Headache Foundation, "Partners in Excellence" Award and in 2016 she won the American Headache Society “Seymour Solomon” Award.

After earning a master’s degree and a doctorate in psychology from the University of Utah, Dr. Buse completed an internship in medical psychology in the Boston VA Medical System and Harvard Medical School and 3 years of postdoctoral fellowships in adult and pediatric headache and pain management at Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Children’s Hospital, Boston, and Harvard Medical School.

Dr. Buse mentors graduate students in the Ferkauf Doctoral Health Psychology program.  Dr. Buse is the psychological and behavioral section editor for Current Pain and Headache Reports and she serves on the advisory board of the Journal of Headache and Pain, Pain Management News, and Pain Pathways Magazine.  She is on the American Headache Society Board of Directors and Electronic Media Committee, and the American Academy of Neurology Digital Strategy Subcommittee.

As a clinical psychologist, Dr. Buse uses biobehavioral techniques which include cognitive behavioral therapy, guided visual imagery, biofeedback and mindfulness training.  She offers free guided visual imagery and relaxation exercises at www.dawnbuse.com.  You can also find abstracts for her articles there.  You can follow her on twitter at @dawnbuse.

Selected Publications

Buse, D.C., Powers, S.W., Gelfand, A.A., VanderPluym, J.H., Fanning, K.M., Reed, M.L., Adams, A.M., Lipton, R.B. Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study. Headache. 2018 Apr;58(4):512-524. doi: 10.1111/head.13254. Epub 2018 Jan 22. PMID: 29355924.

Buse DC, Gillard P, Arctander K, Kuang AW, Lipton RB. Assessing Physician-Patient Dialogues About Chronic Migraine During Routine Office Visits. Headache. 2018 Jul;58(7):993-1006. doi: 10.1111/head.13314. Epub 2018 May 4. PMID: 29727478.

Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA. Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab. Cephalalgia. 2018 Aug 7:333102418789072. doi: 10.1177/0333102418789072. [Epub ahead of print] PMID:30086681

Ashina, S., Lipton, R.B., Bendtsen, L., Hajiyeva, N., Buse, D.C., Lyngberg, A.C., Jensen, R. Increased pain sensitivity in migraine and tension-type headache coexistent with low back pain: A cross-sectional population study. Eur J Pain. 2018 May;22(5):904-914. doi: 10.1002/ejp.1176. Epub 2018 Jan 19. PMID: 29349847.

Steiner, T.J., Buse, D.C., Al Jumah, M., Westergaard, M.L., Jensen, R.H., Reed, M.L., Prilipko, L., Mennini, F.S., Láinez, M.J.A., Ravishankar, K., Sakai, F., Yu, S.Y., Fontebasso, M., Al Khathami, A., MacGregor, E.A., Antonaci, F., Tassorelli, C., Lipton, R.B.; Lifting The Burden: The Global Campaign against Headache. The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility. J Headache Pain. 2018 Feb 14;19(1):15. doi: 10.1186/s10194-018-0842-6. PMID: 29445880.

Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, Dodick DW, Lipton RB. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-z. PMID: 29797100.

Seng EK, Kuka AJ, Mayson SJ, Smitherman TA, Buse DC. Acceptance, Psychiatric Symptoms, and Migraine Disability: An Observational Study in a Headache Center. Headache. 2018 Jun;58(6):859-872. doi: 10.1111/head.13325. PMID: 2992441.

Scher AI, Wang SJ, Katsarava Z, Buse DC, Fanning KM, Adams AM, Lipton RB. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Cephalalgia. 2018 Jan 1:333102418786266. doi: 10.1177/0333102418786266. [Epub ahead of print] PMID: 29996667.

Lipton RB, Fanning KM, Buse DC, Martin VT, Reed ML, Manack Adams A, Goadsby PJ. Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2018 Jul;58(7):933-947. doi: 10.1111/head.13342. Epub 2018 Jul 19. PMID:30024028.

Schroeder RA, Brandes J, Buse DC, Calhoun A, Eikermann-Haerter K, Golden K, Halker R, Kempner J, Maleki N, Moriarty M, Pavlovic J, Shapiro RE, Starling A, Young WB, Nebel RA. Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps. J Womens Health (Larchmt). 2018 Aug;27(8):965-973. doi: 10.1089/jwh.2018.7274. PMID:30129895.

Buse, D.C., Reed, M.L., Fanning, K.M., Kurth, T., Lipton, R.B. Cardiovascular Events, Conditions and Procedures Among People with Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. Jan;57(1):31-44, 2017. PMID: 27861837

Seng, E.K., Buse, D.C., Klepper, J.E., Mayson, S., Grinberg, A.S., Grosberg, B.M., Pavlovic, J.M., Robbins, M.S., Vollbracht, S.E., Lipton, R.B.. Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center. Headache. Apr;57(4):593-604, 2017. PMID: 28139000

Lipton, R.B., Buse, D.C., Adams, A.M., Varon, S.F., Fanning, K.M., Reed, M.L. Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale. Headache. 2017 Feb 10. doi: 10.1111/head.13028. [Epub ahead of print] PMID: 28185239

Ashina, S., Bendtsen, L., Buse, D.C., Lyngberg, A.C., Lipton, R.B., Jensen, R. Neuroticism, depression and pain perception in migraine and tension-type headache. Acta Neurol Scand. 2017 Nov;136(5):470-476. doi: 10.1111/ane.12751. Epub 2017 Mar 5. PMID: 28261782.

Scher, A.I., Buse, D.C., Fanning, K.M., Adams, A.M., Lipton, R.B. Comorbid Pain and Migraine Chronicity: the Chronic Migraine Epidemiology & Outcomes Study. Neurology.  2017 Aug 1;89(5):461-468. doi: 10.1212/WNL.0000000000004177. Epub 2017 Jul 5.PMID: 28679597.

Kawata, A.K., Hsieh, R., Bender, R., Shaffer, S., Revicki, D.A., Bayliss, M., Buse, D.C., Desai, P., Sapra, S., Ortmeier, B., Hareendran, A. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary. Headache. 2017 Oct;57(9):1385-1398. doi: 10.1111/head.13162. Epub 2017 Aug 30. PMID: 28857154.

Lipton, R.B., Munjai, S., Buse, D.C., Bennett, A., Fanning, K.M., Burstein, R., Reed, M.R. Allodynia is associated with initial and sustained response to acute migraine treatment: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2017 Jul;57(7):1026-1040. doi: 10.1111/head.13115. Epub 2017 Jun 11. PMID: 28603893.  American Headache Society, Harold Wolff Award Winner, 2017.

Lipton, R.B., McGinley, J., Shulman, K.J., Wirth, R.J., Buse, D.C. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) vs. Oral Sumatriptan: Results from the COMPASS Study. Headache. 2017 Nov;57(10):1570-1582. doi: 10.1111/head.13165. Epub 2017 Sep 7. PMID: 28880380.

Lipton, R.B., Reed, M.L., Kurth, T., Fanning, K.M., Buse, D.C. Framingham Based Cardiovascular Risk Estimates among People with Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2017 Nov;57(10):1507-1521. doi: 10.1111/head.13179. Epub 2017 Oct 9. PMID: 28990165.

Serrano, D., Lipton, R.B., Scher, A.I., Reed M.L., Stewart, W.F., Adams, A.M., Buse, D.C. Fluctuations in Episodic and Chronic Migraine Status over the Course of One Year: Implications for Diagnosis, Treatment and Clinical Trial Design.  Journal of Headache and Pain, 2017 Oct 4;18(1):101. doi: 10.1186/s10194-017-0787-1. PMID: 28980171. Winner of the 2017 Enrico Greppi Award. 

Patel, Z.S., Hoffman, L.K., Buse, D.C., Grinberg, A.S., Afifi, L., Cohen, S.R., Lowes, M.A., Seng, E.K. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected]. Curr Pain Headache Rep. 2017 Nov 1;21(12):49. doi: 10.1007/s11916-017-0647-3. Review. Erratum in: Curr Pain Headache Rep. 2017 Nov 18;21(12 ):52. PMID: 29094219.

Hareendran, A., Mannix, S., Skalicky, A., Bayliss, M., Blumenfeld, A., Buse, D.C., Desai, P.R., Ortmeier, B.G., Sapra, S. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID). Health Qual Life Outcomes. 2017 Nov 17;15(1):224. doi: 10.1186/s12955-017-0799-1. PMID: 29149901.

Patel, Z.S., Hoffman, L.K., Buse, D.C., Grinberg, A.S., Afifi, L., Cohen, S.R., Lowes, M.A., Seng, E.K. Correction to: Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa. Curr Pain Headache Rep. 2017 Nov 18;21(12):52. doi: 10.1007/s11916-017-0653-5. PMID: 29151223.

Lipton, R.B., McGinley, J.S., Shulman, K.J., Silberstein, S.D., Wirth, R.J., Buse, D.C. AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial. Headache. 2018 Feb;58(2):229-242. doi: 10.1111/head.13199. Epub 2017 Oct 16. PMID: 29034453.

Thomas JG, Pavlovic J, Lipton RB, Roth J, Rathier L, O'Leary KC, Buse DC, Evans EW, Bond DS. Ecological momentary assessment of the relationship between headache pain intensity and pain interference in women with migraine and obesity. Headache, 2016Cephalalgia. 2016 Nov 1;36(13):1228-1237. Epub 2016 Jan 6. PMID: 26742779

Messali A, Sanderson JC, Blumenfeld AM, Goadsby PJ, Buse DC, Varon SF, Stokes M, Lipton RB. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey. Headache. Feb;56(2):306-22, 2016. PMID: 26833083.

Martin VT, Pavlovic J, Fanning KM, Buse DC, Reed ML, Lipton RB. Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study. Headache. Feb;56(2):292-305, 2016.

Martin V.T, Fanning K.M., Serrano D., Buse D.C., Reed M.L., Lipton R.B. Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study. Headache. Jan;56(1):118-31, 2016.

Mannix, S., Skalicky, A., Buse, D.C., Desai, P., Sapra, A., Ortmeier B., Widnell, K., Hareendran. Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches. Health and Quality of Life Outcomes, 14:143, 2016.

Lipton, R.B., Serrano, D., Buse, D.C., Pavlovic, J.M., Blumenfeld, A.M., Dodick, D.W., Aurora, S.K., Becker, W.J., Diener, H.C., Wang, S.J., Vincent, M.B., Hindiyeh, N.A., Starling, A.J., Gillard, P.J., Varon, S.F., Reed, M.L. Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM). Cephalalgia. Mar;36(3):203-15, 2016.

Lipton, R.B., Munjai, S., Buse, D.C., Fanning, K.M., Bennett, A., Reed, M.L. Predicting Inadequate Response to Acute Migraine Medication: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. Nov;56(10):1635-1648, 2016. PMID: 27731896

Lipton, R.B., Manack Adams, A., Buse, D.C., Fanning, K.M., Reed, M.L. A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: demographics and headache-related disability. Headache. Sep;56(8):1280-9, 2016.

Dodick, D.W., Loder, E.W., Manack Adams, A., Buse, D.C., Fanning, K.M., Reed, M.L., Lipton, R.B. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2016; doi: 10.1111/head.12774.

Buse, D.C., Scher, A.I., Dodick, D.W., Reed, M.L., Fanning, K.M., Manack-Adams, A., Lipton, R.B.  Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study. Mayo Clin Proc. 91(5):596-611, 2016.

Lipton, R.B., Fanning, K.M., Serrano, D., Reed, M.L., Cady R., Buse, D.C. Ineffective acute treatment of episodic migraine is associated with new onset chronic migraine. Neurology 17;84(7):688-95 2015.

Singer, A.B., Buse, D.C., Seng, E.K. Behavioral Treatments for Migraine Management: Useful at each Step of Migraine Care. Current Neurology and Neuroscience Reports 15(4):14, 2015.

Serrano, D., Buse, D.C., Manack Adams, A., Reed, M.L., Lipton, R.B. Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache 55(4):502-18, 2015.

Reed, M.L., Fanning, K.M., Serrano, D., Buse, D.C., Lipton R.B. Persistent frequent nausea is associated with progression to chronic migraine: AMPP Study Results, Headache 55(1):76-87 2015.

Tietjen, G.E., Buse, D.C., Fanning, K.M., Serrano, D., Reed, M.L., Lipton, R.B. Recalled Maltreatment, Migraine and Tension-Type Headache: Results of the AMPP Study. Neurology 13;84(2):132-40 2015.

Pavlović, J.M., Stewart, W.F., Bruce, C.A., Gorman, J.A., Sun, H., Buse, D.C., Lipton, R.B.  Burden of migraine related to menses: results from the AMPP study.  Journal of Headache and Pain 18;16(1):24, 2015.

Geraghty M.E., Buse D.C. The Biopsychosocialspiritual Impact of Chronic Pain, Chronic Illness, and Physical Disabilities in Adolescence. Curr Pain Headache Rep. Nov;19(11):526, 2015. PMID: 26351154.

Buse, D.C., Serrano, D., Reed, M.L., Kori, S.H., Cunanan, C.M., Adams, A.M., Lipton, R.B.Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Headache.  Jun;55(6):825-39, 2015.

Boudreau, G.P., Grosberg, B.M., McAllister, P.J., Sheftell, F.D., Lipton, R.B., Buse, D.C.  Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety. International Journal of General Medicine 18;9:79-86, 2015.

Bond D.S., Buse D.C., Lipton R.B., Thomas J.G., Rathier L., Roth J., Pavlovic J.M., Evans E.W., Wing R.R. Clinical Pain Catastrophizing in Women With Migraine and Obesity. Headache. Jul-Aug;55(7):923-33, 2015. PMID: 26087348.

Adams, A.M., Serrano, D., Buse, D.C., Reed, M.L., Marske, V., Fanning, K.M., Lipton, R.B. The Impact of Chronic Migraine: The CaMEO (Chronic Migraine Epidemiology and Outcomes) Study Methods and Baseline Results. Cephalalgia 35(7):563-78, 2015.

Lipton, R.B./ Serrano, D., Pavlovic, J.M., Manack, A.N., Turkel, C.C., Reed, M.L., Buse, D.C.Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.. Headache 54(5):830-49, 2014.

Lipton, R.B., Pavlovic, J.M., Haut, S.R., Grosberg, B.M., Buse, D.C. Methodological issues in studying trigger factors and premonitory features of migraine. Headache 54(10):1661-9 2014.

Lipton, R.B., Buse, D.C., Hall, C.B., Tennen, H., DeFreitas, T.A., Borkowski, T.M., Grosberg, B.M., Haut, S.R. Reduction in Perceived Stress as a Migraine Trigger: Testing the “Let-down Headache” Hypothesis, Neurology 82(16):1395-40, 2014.

Pavlovic, J.M., Buse, D.C., Sollars, C.M., Haut, S.H., Lipton, R.B. Trigger factors and premonitory features of migraine attacks: Summary of studies.  Headache 54(10):1670-9 2014.

Martin, V.T., Fanning, K.M., Serrano, D. Buse, D.C., Reed, M.L., Bernstein, J.A., Lipton, R.B. Chronic Rhinitis and its Association with Headache Frequency and Disability in Persons with Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study, Cephalalgia Apr;34(5):336-48, 2014.

Serrano S, Manack, AN, Reed ML, Buse DC, Varon SF, Lipton RB. Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Value in Health 16(1):31-8, 2013.

Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the Diagnosis and Treatment of Migraine: Effects of Sex, Income and Headache Features. Headache 53(1):81-92, 2013.

Lipton, R.B., Buse, D.C., Saiers, J., Fanning, K.M., Serrano, D., Reed, M.L. Frequency and Burden of Headache-Related Nausea: Results from the AMPP Study. Headache 53(1):93-103, 2013.

Westergaard, M.L.S., Steiner, T.J., MacGregor, E.A., Antonaci F., Tassorelli C., Buse, D.C., Lipton, R.B., Jensen, R.H. The Headache Under-Response to Treatment (HURT) Questionnaire: Assessment of utility in headache specialist care. Cephalalgia Mar;33(4):245-55, 2013.

Blumenfeld A.M., Bloudek L.M., Becker W.J., Buse D.C., Varon S.F., Maglinte G.A., Wilcox T.K., Kawata A.K., Lipton R.B. Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II). Headache: The Journal of Head and Face Pain 2013; 53(4), 644–655.

Lipton, R. B., Buse, D.C., Saiers, J., Serrano, D., Reed, M.L.  Healthcare Resource Utilization and Direct Costs Associated with Frequent Nausea in Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.  Journal of Medical Economics 16(4),490-499, 2013.

Holland, S., Fanning, K.M., Serrano, D., Buse, D.C., Reed, M.L., Lipton, R.B.  Rates and Reasons for Discontinuation of Triptans and Opioids Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Journal of the Neurological Sciences 326, 1–2(15):10–17, 2013.

Lipton, R.B., Buse, D.C., Serrano, D., Holland, S., Reed, M.L. Examination of Unmet Treatment Needs among Persons with Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache 53(8):1300-11, 2013.

Serrano D, Buse DC, Kori SH, Papapetropoulos S, Cunanan CM, Manack AN, Reed ML, Lipton RB. Effects of Switching Acute Treatment on Disability in Migraine Patients Using Triptans. Headache 53(9):1415-29, 2013.

Buse, D.C., Silberstein, S.D., Manack, A.N., Papapetropoulos, S., Lipton R.B. Psychiatric comorbidities of episodic and chronic migraine. Journal of Neurology 260(8)8: 960-1969, 2013.

Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano, D, Lipton RB. Sex Differences in Prevalence, Symptoms, and other Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention Study. Headache 53(8):1278-99, 2013.

Al Jumah MAl Khathaami ATamim HAl Owayed AKojan SJawhary ALipton RBuse DJensen RSteiner T. HURT (Headache Under-Response to Treatment) Questionnaire in the management of primary headache disorders. Reliability, validity and clinical utility of the Arabic version. The Journal of Headache and Pain 14:16, 2013.

Hough S, Stone MT, Buse DC. Dating and Relationship Psychoeducational Group for Veterans with Spinal Cord Injury/Dysfunction: A Historical Account of an Initial Clinical Course. Sexuality and Disability 31(4):337-359, 2013.

Sanderson, J.C., Devine, E.B., Lipton, R. B., Bloudek, L.M., Varon, S.F., Blumenfeld, A.M., Goadsby, P.J., Buse, D.C., Sullivan, S.D. Headache-related health resource utilisation in chronic and episodic migraine across six countries. Journal of Neurology, Neurosurgery, and Psychiatry  84(12):1309-17, 2013.

Lipton, R.B., Serrano, D., Nicholson, R.A., Buse, D.C., Runken, M.C., Reed, M.L. Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 53(10):1548-63, 2013.

Buse, D.C., Manack, A.N., Serrano, D., Varon, S.F., Turkel, C.C., Reed M.L., Lipton RB. Headache-Impact of Chronic and Episodic Migraine: Results from the AMPP Study. Headache 52(1), 3-17, 2012.

Buse, D.C., Pearlman, S.H., Reed, M.L., Serrano, D., Ng-Mak, D.S., Lipton, R.B. Opioid Use and Dependence among Persons with Migraine: Results of the AMPP Study. Headache 52(1), 18-36, 2012.

Chu, M.K., Buse, D.C., Bigal, M.E., Serrano, D., Lipton, R.B. Factors associated with triptan use in episodic migraine: Results from the American Migraine Prevalence and Prevention Study (AMPP). Headache 52(2), 213-223, 2012.

Robbins, MS, Bronheim, R, Lipton, RB, Grosberg, BM, Vollbracht, S, Sheftell, FD, Buse DC. Depression and anxiety in episodic and chronic cluster headache: a clinic-based, cross-sectional study.  Headache 52(4), 600-611, 2012.

Bloudek, LM, Stokes, M., Buse, D.C., Wilcox, T.K, Lipton, R.B., Goadsby, P.J., Varon, S.F, Blumenfeld, A.M., Katsarava, Z., Pascual, J., Lanteri-Minet, M., Cortelli, P., Martelletti, P. Cost of Healthcare for Patients With Migraine in Five European Countries: Results From the International Burden of Migraine Study (IBMS). Journal of Headache and Pain 13(5), 361-378, 2012.

Buse, D.C., Manack, A.N., Fanning, K., Serrano, D., Reed, M.L., Turkel, C.C., Lipton, R.B.  Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results from the American Migraine Prevalence and Prevention Study. Headache 52(10), 1456-1470, 2012.

Ashina, S., Serrano, D., Lipton, R.B., Maizels, M., Manack, A.N., Turkel, C.C., Reed, M.L., Buse, D.C.  Depression and risk of transformation of episodic to chronic migraine: Results of the American Migraine Prevalence and Prevention Study. Enrico Greppi Award 2012. Journal of Headache and Pain 13:615–624, 2012.

Blumenfeld, A.M., Varon, S.F., Wilcox, T.K., Buse, D.C., Kawata, A.K., Manack, A., Goadsby, P.J., Lipton, R.B. Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia 31:301-315, 2011.

Manack, A., Buse, D., Serrano, D., Turkel, C., Lipton, R.B.  Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76:711-718, 2011.

Payne, K.A., Varon, S.P., Kawata, A.K., Yeoman’s, K., Wilcox, T.K., Manack, A., Buse, D.C, Lipton, R.B., Goadsby, P.J., Blumenfeld, A.M. The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics. Cephalalgia 31:1116-1130, 2011.

Stewart, W.F., Wood, C., Bruce, C.B., Buse, D.C., Runken, M.C., Lipton, R.B. Longitudinal change in migraine headache-days and indirect cost consequences. Journal of Occupational and Environmental Medicine 53:477-486, 2011.

Stokes, M.S., Werner, J.B., Lipton, R.B., Sullivan, S.D., Wilcox, T.K., Wells, L., Manack, A., Proskorovsky, I., Gladstone, J., Buse, D.C., Varon, S.F., Goadsby, P.J., Blumenfeld, A.M. Cost of health care among patients with chronic migraine and episodic migraine in Canada and the USA: Results from the International Burden of Migraine Study (IBMS). Headache 51:1058-1077, 2011.

Napchan, U., Buse, D.C., Loder, E.W. The use of marijuana or synthetic cannabinoids for the treatment of headache. Headache 51(3):502-505, 2011.

Stewart, W.F., Bruce, C., Manack, A., Buse, D.C., Varon, S.F., Lipton, R.B. A case study for calculating employer costs for lost productive time in episodic migraine and chronic migraine: Results of the American Migraine Prevalence and Prevention Study. J Occup Environ Med. 2011 Oct;53(10):1161-71. 

Buse, D.C., Manack, A., Serrano, D., Turkel, C., Lipton, R.B. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg and Psychiatry 81:428-432, 2010.

Stewart W.F., Wood G.C., Manack A., Varon S.F., Buse D.C., Lipton R.B. Employment andwork impact of chronic migraine and episodic migraine. J Occup Environ Med 52:8-14, 2010

Bigal, M.E., Kurth, T.K., Santanello, N., Buse, D.C., Golden, W., Robbins, M., Lipton, R.B.  Migraine and cardiovascular disease: A population-based study. Neurology 74:628-635, 2010.

Bigal, M.E., Golden, W., Buse, D.C., Chen, Y.T., Lipton, R.B. Triptan use as a function of cardiovascular risk. A population-based study. Headache 50:256-263, 2010.

Victor, T.W., Hu, X., Campbell, J., Schuler, K.W., Buse, D.C., Lipton, R.B. Migraine Prevalence by age and sex in the US: A life span study. Cephalalgia 30:1065-1072, 2010.

Victor, T.W., Hu, X., Campbell, J., White, R.E., Buse, D.C., Lipton, R.B. Association between  migraine, anxiety and depression. Cephalalgia 30:567-575, 2010.

Bigal, M.E., Buse, D.C., Chen, Y.T., Golden, W., Serrano, D., Chu, M.K., Lipton, R.B. Rates and predictors of starting a triptan: Results from the American Migraine Prevalence and Prevention Study. Headache 50:1440-1448, 2010.

Bigal, M.E., Serrano, D., Buse, D., Scher, A., Stewart, W.F., Lipton, R.B. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 48:1157-1168, 2008.

Bigal, M.E., Ashina, S., Burstein, R., Reed, M.L., Buse, D., Serrano, D., Lipton, R.B. Prevalence and characteristics of allodynia in headache sufferers: A population study. Neurology 70:1525-1533, 2008.

Scher, A.I., Stewart, W.F., Buse, D., Krantz, D.S., Lipton, R.B. Major life changes before and after the onset of chronic daily headache: A population-based study. Cephalalgia 28:868-876, 2008.

Bigal, M.E., Serrano, D., Buse, D., Scher, A., Stewart, W.F., Lipton, R.B. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache 48:1157-1168, 2008.

Katz N P; Buse D C; Budman S H; Wing Venuti S; Fernandez K C; Benoit C; Bianchi R; Cooper D; Jasinski D R; Smith D E; Butler S F. Development and preliminary experience with an ease of extractability rating system for prescription opioids. Drug development and industrial pharmacy 2006;32(6):727-46.

Markley Herbert G; Buse Dawn C. Cluster headache: myths and the evidence. Current pain and headache reports 2006;10(2):137-41.

Loder Elizabeth W; Buse Dawn C; Golub Joan R. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. American journal of obstetrics and gynecology 2005;193(3 Pt 1):636-49.

Loder Elizabeth W; Buse Dawn C; Golub Joan R. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice. Headache 2005;45(3):224-31.

Lindamer Laurie A; Buse Dawn C; Auslander Lisa; Unützer Jürgen; Bartels Steven J; Jeste Dilip V. A comparison of gynecological variables and service use among older women with and without schizophrenia. Psychiatric services (Washington, D.C.) 2003;54(6):902-4.

Lindamer L A; Buse D C; Lohr J B; Jeste D V. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biological psychiatry 2001;49(1):47-51. 

More Information About Dr. Dawn Buse

Montefiore Headache Center

Dr. Buse Relaxation Audiocasts: Deep Breathing & Guided Visual Imagery

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Montefiore Medical Center
1250 Waters Place
Tower 2
Bronx, NY 10461

Tel: 718.405.8360
Fax: 929.263.3951

Research Information